The Causes of Underdiagnosing Akathisia
Overview
Authors
Affiliations
This article reviews what causes clinicians to overlook or underdiagnose akathisia. The causes are considered to be related to both the patient's symptoms and the clinician's attitude toward akathisia. The patient factors include mild severity of akathisia, lack of apparent motor restlessness, no voluntary expression of inner restlessness, no clear communication of inner restlessness, restlessness in body parts other than the legs, atypical expressions of inner restlessness, other prominent psychic symptoms, and absence of other extrapyramidal signs. The clinician factors include emphasis on objective restlessness, failure to consider akathisia during antipsychotic therapy, failure to fully implement antiakathisia treatments in ambiguous cases, and strict adherence to research diagnostic criteria. Akathisia is likely to be overlooked or underdiagnosed when both patient and clinician factors are present. Currently, there may be two major problems with underdiagnosis: (1) symptoms that fulfill the diagnostic criteria for akathisia are overlooked, and (2) conditions that do not fulfill the diagnostic criteria but can still benefit from antiakathisia measures are underdiagnosed.
Akathisia superimposed to Hashimoto's encephalopathy in an old lady.
Isik A, Kaya D, Altunkalem Seydi K Acta Biomed. 2022; 93(S1):e2022120.
PMID: 35786633 PMC: 10510957. DOI: 10.23750/abm.v93iS1.11828.
Musco S, McAllister V, Caudle I Ther Adv Psychopharmacol. 2020; 10:2045125320937575.
PMID: 32922732 PMC: 7457694. DOI: 10.1177/2045125320937575.
"Phantom akathisia" in an amputated leg of a sarcoma patient: a case report.
Ishida M, Imanishi J, Yazawa Y, Sunakawa Y, Torigoe T, Onishi H Biopsychosoc Med. 2020; 14:4.
PMID: 32165917 PMC: 7060569. DOI: 10.1186/s13030-020-00178-8.
Demyttenaere K, Detraux J, Racagni G, Vansteelandt K CNS Drugs. 2019; 33(6):549-566.
PMID: 31065941 DOI: 10.1007/s40263-019-00625-3.
Physical Health Outcomes in Preschoolers with Prior Authorization for Antipsychotics.
Wei Y, Liu X, Rao N, McPherson M, Jones M, Bussing R J Child Adolesc Psychopharmacol. 2017; 27(9):833-839.
PMID: 28708433 PMC: 5824663. DOI: 10.1089/cap.2017.0006.